---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-025520"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T16:58:54.680907+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Zura Bio provides updated corporate presentation; no financial results disclosed

## Summary
- Updated corporate presentation furnished as Exhibit 99.1 for use at conferences and investor meetings.
- Presentation available on company website at investors.zurabio.com.
- No specific financial, clinical, or operational updates are included in the filing text.

## SEC filing metadata
- accession: 0001104659-26-025520
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465926025520/0001104659-26-025520-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465926025520/tm268344d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-025520
- JSON: https://secwatch.observer/filing/0001104659-26-025520.json
- Plain text: https://secwatch.observer/filing/0001104659-26-025520.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
